ArticleCancer cell2018

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.

Maria Kleppe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.